The effect of various anti-immunoglobulin G (IgG) antibodies on the complement-mediated lysis of herpes simplex virus-infected human fibroblasts was determined. IgM rheumatoid factor, a naturally occurring anti-human Fc, inhibited lysis, whereas rabbit anti-human IgG serum potentiated immune cytolysis. We attempted to explain this disparity by determining the effect various classes of anti-IgG's with differing specificities had on complementmediated lysis. Inhibition of cytolysis occurred with IgM anti-Fc and all of the IgG antiglobulins (anti-IgG, Fab, and Fc). In contrast, IgM anti-Fab enhanced lysis. IgM anti-IgG suppressed immune cytolysis when high concentrations of antiviral serum were incubated with the virus-infected cell, but augmented lysis when low concentrations of anti-herpes simplex virus antibody were exposed to the fibroblasts. The experiments indicated that whether a particular antiglobulin potentiates or inhibits lysis depends on the concentration of antibody bound to the target cells as well as the class and specificity of the antiglobulin exposed to the antibody-coated cell.
The effect of various anti-immunoglobulin G (IgG) antibodies on the complement-mediated lysis of herpes simplex virus-infected human fibroblasts was determined. IgM rheumatoid factor, a naturally occurring anti-human Fc, inhibited lysis, whereas rabbit anti-human IgG serum potentiated immune cytolysis. We attempted to explain this disparity by determining the effect various classes of anti-IgG's with differing specificities had on complementmediated lysis. Inhibition of cytolysis occurred with IgM anti-Fc and all of the IgG antiglobulins (anti-IgG, Fab, and Fc). In contrast, IgM anti-Fab enhanced lysis. IgM anti-IgG suppressed immune cytolysis when high concentrations of antiviral serum were incubated with the virus-infected cell, but augmented lysis when low concentrations of anti-herpes simplex virus antibody were exposed to the fibroblasts. The experiments indicated that whether a particular antiglobulin potentiates or inhibits lysis depends on the concentration of antibody bound to the target cells as well as the class and specificity of the antiglobulin exposed to the antibody-coated cell.
A variety of antiglobulins can be found in the sera of"healthy" (17, 23, 29) as well as diseased patients (17, 20, 28) . The most extensively studied group of naturally occurring antiglobulins has been the rheumatoid factors (RFs) . These "anti-antibodies" react with the Fc portion of human immunoglobulin G (IgG) (29) . Although IgM, IgG, and IgA RFs have all been described (32) , IgM RFs have been best characterized.
IgM RF appears in the convalescent sera of patients with a variety of viral diseases, including hepatitis B (10, 23) , influenza A (31), rubella (20) , Epstein-Barr (9) , and cytomegalovirus infections (22) . In vitro, RF has been shown to potentiate the complement-mediated neutralization of herpes simplex virus (HSV) (1)-and vaccinia virus-antibody complexes (14) ; however, the role this antiglobulin may play in vivo is at present unclear. In a previous study we examined the effect RF and goat anti-human IgG had on the complement-mediated lysis of vaccinia virus-infected cells (13) . Antiserum to human IgG was found to inhibit lysis when high amounts of antiviral antibody were incubated with the infected cells and potentiated lysis when low concentrations of antiviral serum were exposed to the cells. In contrast to anti-IgG, RF only inhibited immune lysis. In this report we sought to explain the disparity between anti-IgG and RF. We determined the effect the class and specificity of the anti-IgG had on complement-mediated lysis of human fibroblasts. In this study we have shown that both the class and specificity of the anti-IgG antibody are important factors in determining whether potentiation or inhibition of complement-mediated lysis occurs.
MATERIALS AND METHODS
Virus and antiviral serum. HSV, strain CHR-HSV-3, was grown in primary rabbit kidney cultures and assayed as plaque-forming units on primary rabbit kidney cells, using a human anti-HSV overlay (17) . The antiviral serum, obtained by multiple bleedings from a volunteer with recurrent herpes labialis, was heat inactivated at 56°C for 30 min and stored at -26°C until used. ' IgG fragments. Human IgG was prepared by diethylaminoethyl-cellulose (Whatman DE-52, Clifton, N.J.) chromatography of pooled human sera (11) . The IgG fraction was subjected to papain digestion (Mercuripapain; Worthington Biochemicals, Freehold, N.J.), and ion-exchange chromatography was used to obtain Fab and Fc fragments (12 Antiglobulin sera. Rabbit antisera to either human IgG, Fab, or Fc were prepared by immunizing 8-week-old, New Zealand white male rabbits. A 10-mg amount of the respective antigen was dissolved in 1.0 ml of PBS and injected intravenously. Simultaneously, 0.5 mg of each antigen was dispersed in 0.25 ml of Freund complete adjuvant (Difco Laboratories, Detroit, Mich.), and 0.06 ml was injected into each of the four footpads. A 5-mg intravenous booster of the respective antigen in PBS was given to each rabbit at 10, 17, 24, and 31 days after the primary immunization. The antiglobulin sera were obtained from the rabbits 8 days after the last booster, heat inactivated at 560C for 30 min, and stored at -260C until used. Anticomplementary activity in these antisera was tested for by incubating the antisera with a 1:5 dilution of guinea pig complement (GPC) for 1 h at 370C. Sufficient lytic activity remained in this mixture to lyse sensitized sheep erythrocytes.
Isolation of IgG and IgM from serum. IgM was obtained by chromatography of sera on Sephadex G-200 (Pharmacia Fine Chemicals, Piscataway, N.J.). After chromatography, each IgM-containing fraction was concentrated by membrane ultrafiltration (Amicon Corp., Lexington, Mass.) to one-half the original serum volume and stored at -70'C until used. Rabbit IgM (10 mg of protein per ml) was free from IgG and IgA by immunodiffusion against goat anti-rabbit IgG and IgA (Hyland Laboratories, Costa Mesa, Calif.) and agglutinated human IgGcoated latex particles to a dilution of 1:32 to 1:64.
RF was isolated from sera of patients with latexpositive rheumatoid arthritis by G-200 chromatography as described by Schrohenloher et al. (28) . After concentration of the IgM fraction to one-half the original serum volume, this RF-containing eluate was free from IgG and IgA by immunodiffusion and had a latex agglutination titer of 1:2,000.
The IgG preparations were obtained by diethylaminoethyl-cellulose chromatography of whole serum, dialyzed against distilled water, and lyophilized. At 10 mg/ml this IgG-containing material was free from IgM and IgA when tested by immunodiffusion and agglutinated IgG-coated latex particles to a dilution of 1:32 to 1:64. When tested by immunodiffusion, the IgM and IgG anti-Fab and anti-Fc preparations were found to be specific for their respective antigens.
Immune lysis assay. The 5'Cr lysis assay was an adaptation of the method described by Brier et al. (7) . Human embryonic foreskin fibroblasts (Flow 7000; Flow Laboratories, Rockville, Md.) were trypsinized and grown in Linbro Multi-Dishes (model IS-FB-96; Linbro Chemical Co., New Haven, Conn.), using Eagle minimal essential medium with 10% fetal bovine serum (EMFBS). Confluent monolayers (103 cells/well) were labeled for 4 h at 37°C (all incubations were done at 37°C in a humidified CO2 incubator) by incubating the fibroblasts with 0.5 ,Ci of Na251Cr207 (New England Nuclear Corp., Boston, Mass.) in 0.05 ml of medium per well. Cells were then exposed to HSV at a multiplicity of 100 plaque-forming units per cell or medium (uninfected control). At 14 h postinfection the fibroblasts were washed twice with EMFBS and the monolayers were incubated for 1 h with anti-HSV serum or medium. The anti-HSV was removed, the monolayers were washed, and the cells were overlaid with antiglobulins or medium (control) for 1 h. The monolayers were washed twice to remove unattached antiglobulins and then incubated with a 1:5 dilution (all dilutions were made in EMFBS) of either fresh or heatinactivated (control) GPC (Suburban Serum Supplies, Silver Spring, Md.). This last incubation was for 90 min, after which the supernatant and the remaining cells were assayed for radioactivity (Packard Autogamma spectrometer; Packard Instrument Co., Downers Grove, Ill.).
The percent lysis was calculated by the following formula: % lysis = [(counts per minute in supernatant)/(counts per minute in supernatant and counts per minute in cells)] x 100.
The inhibition or potentiation of lysis produced by the antiglobulins was determined as compared with the cells incubated with medium instead of antiglobulin. The data presented represent the mean of at least two experiments done in duplicate with one standard deviation where indicated in the figures. The Student t test for comparing mean values was applied, and values were considered significant if the P value was 0.05 or less.
RESULTS
Lysis of HSV-infected fibroblasts by human antiviral serum and complement. The first experiment determined whether sufficient viral antigens would be expressed on human fibroblasts to allow lysis by human anti-HSV serum and GPC. Figure 1A shows that maximal lysis occurred with undiluted serum. At this concentration of antiviral serum approximately 3,000 cpm of 5'Cr was released, and this corresponded to lysis of approximately 35% of the infected fibroblasts (Fig. 1B) . Undiluted serum with heat-inactivated GPC or medium containing active GPC did not cause significant 5'Cr release of infected cells. As the concentration of anti-HSV serum incubated with the infected cells decreased, the amount of lysis obtained by the addition of complement correspondingly decreased. At a serum dilution of 1:64 or greater, no 51Cr release occurred above the background level.
Effect of RF on immune lysis. We next determined the effect of RF on the complementmediated lysis of the antibody-coated, virusinfected cells. Fibroblasts were chromium labeled, infected with virus, and treated with antiviral serum as described above. In these and subsequent experiments, antiglobulins were added, the cells were again washed, and complement was incubated with the fibro- enhanced the lysis of HSV-infected cells (Fig.  3) . The anti-IgG serum inhibited lysis when high anti-HSV concentrations were exposed to the cells and significantly potentiated lysis (P < 0.05) when lesser amounts of antiviral antibody were used. The anti-IgG serum used in the above and the previously published experiments (13) contained various classes of anti-IgG globulin, each of which had reactivity against the Fc as well as the Fab portion of IgG. We next sought to better characterize the effects of antiglobulins on complement-mediated lysis by using defined classes of anti-IgG antibodies with known specificities.
Effect of rabbit IgG antiglobulins on complement-mediated lysis. Antibodies were purified from the sera of rabbits immunized with either whole human IgG or its Fab or Fc fragments. These IgG antiglobulins were then tested for their effects on immune cytolysis (Fig. 4) Rabbit IgM antiglobulins were used to determine whether this class of antibody would potentiate lysis. The effect that these IgM antiglobulins had on complement-mediated immune lysis was highly dependent on the concentration of antiviral antibody incubated with the cells (Fig. 5) . The rabbit IgM anti-human Fab only enhanced lysis with low concentrations of anti-HSV, yet no effect on cytolysis was noted when large amounts of antiviral serum were incubated with the virus-infected cells. In contrast, the IgM anti-human Fc substantially inhibited lysis at high concentrations of anti- anti-HSV serum. After the cells were washed, they were exposed to medium (control) or IgM antiglobulins (7.5 mg/ml). After 1 h at 379C the cells were washed, GPC or heated complement was added, and the percent inhibition or enhancement of lysis was determined as compared with the control. VOL. 15, 1977 on October 16, 2017 by guest http://iai.asm.org/ 482 SHVERS AND DANIELS HSV, but had no significant effect (P > 0.10) when lesser amounts of antiviral serum were incubated with the cells. Similar to the antiIgG serum (Fig. 3) , the IgM anti-human IgG enhanced the lysis of virus-infected monolayers when low concentrations of anti-HSV were exposed to the cells, yet inhibited cytolysis of fibroblasts incubated with high concentrations of antiviral serum (Fig. 5) . With all of the IgM antiglobulins examined, the inhibition or enhancement of lysis was dependent on the concentration of the antiglobulins used (Fig. 6) . DISCUSSION As shown in this and prior studies (13) , RF and antiglobulin sera can both inhibit and enhance the complement-mediated lysis of antibody-coated cells. Whether the anti-globulin suppresses or augments cytolysis depends on a variety of factors.
The type of cell selected for study greatly influences the results obtained with antiglobulins. As shown in this study, RF (Fig. 2) and all of the IgG antiglobulins (Fig. 4) only inhibited the complement-mediated lysis of antibodycoated, virus-infected fibroblasts. In other studies involving erythrocytes, however, both RF (27) and 7S anti-IgG (19) repair membranous lesions produced by complement (6, 25) , whereas erythrocytes have not been shown to possess such recovery mechanisms. RF and the IgG antiglobulins, upon attaching to the cell-bound antibody, should be able to activate complement as they do when they interact with antigen-antibody complexes in solution (3) . Perhaps, RF and IgG antiglobulins may not be able to insert complement components into the membrane of the nucleated cell at a sufficient rate to overcome the ability of the eukaryotic cell to repair the membrane lesion, and thus lysis does not take place.
Whether the antiglobulin potentiates or inhibits complement-mediated lysis also depends on the concentration of antibody used to sensitize the cell. As shown in Fig. 2 , when high concentrations of antiviral serum were incubated with the HSV-infected cells, anti-IgG serum inhibited complement-mediated lysis. If lower amounts of anti-HSV antibody were exposed to the fibroblasts, this antiglobulin potentiated lysis. Similar results have been obtained using RF and sheep erythrocytes sensitized with low and high concentrations of antierythrocyte antibody (27) . The above results may be explained by considering steric phenomena operative in the binding of antiglobulins and complement to the sensitized cell. When high concentrations of cell-bound antibodies are attached, the binding of antiglobulins to the immunoglobulins coating the cell would only serve to sterically inhibit the further attachment of complement. Under these circumstances, inhibition of immune lysis might occur. In settings in which relatively few cell-bound antibodies are attached, the addition of antiglobulins to these antibody-coated cells could potentially introduce new complementfixing sites on the target cells and augment immune lysis.
As shown in this study, the class of the antiglobulin also has an influence on whether the anti-IgG causes inhibition or potentiation of complement-mediated lysis. IgG anti-Fc only suppressed lysis (Fig. 3) , whereas IgM anti-Fab significantly potentiated immune cytolysis (Fig. 5) . IgM antibodies are known to be very efficient in activating complement (5) , and indeed only one cell-bound IgM molecule is capable of lysing an erythrocyte in the presence of complement (4) . IgG, in contrast, is less efficient and requires at least a doublet to activate the complement cascade (4, 5) . This may explain why the IgM anti-Fab globulin after binding to the antibody-coated, virus-infected cell potentiated lysis, whereas augmentation was not noted with the IgG anti-Fab.
Finally, the specificity of the anti-IgG anti- body will markedly influence whether a particular antiglobulin potentiates or inhibits complement-mediated cytolysis of the antibodycoated, virus-infected fibroblasts. As shown in Fig. 3 , IgM anti-Fab antibody augmented the lysis of the antiviral serum-treated cells, whereas RF and the rabbit IgM anti-Fc (Fig. 5) significantly inhibited cytolysis. The data suggest that the closer the IgM antiglobulin binds to the surface of the cell, the less likely this anti-immunoglobulin will produce inhibition and the greater the probability that it will cause potentiation of complement-mediated lysis.
